Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: A case-control study

被引：51

作者：

Scatizzi M. ^{[1
]}

Kröning K.C. ^{[1
]}

Lenzi E. ^{[1
]}

Moraldi L. ^{[1
]}

Cantafio S. ^{[1
]}

Feroci F. ^{[1
]}

机构：

[1] General Surgery Unit, Ospedale Misericordia e Dolce, 59100 Prato, PO

来源：

Updates in Surgery | 2011年 / 63卷 / 1期

关键词：

Gastrectomy; Gastric cancer; Laparoscopy; Lymph node dissection;

D O I：

10.1007/s13304-011-0043-1

中图分类号：

学科分类号：

摘要：

In a non-specialized setting, laparoscopic distal gastrectomy (LDG) for locally advanced diseases remains controversial, particularly given to the technical demands of the learning curve required to perform an adequate resection with D2 lymph node dissection. Inclusion criteria for this statistically generated matching controlled study were all patients who underwent subtotal laparoscopic gastrectomies from January 2006 until September 2009 for locally advanced gastric adenocarcinoma (stage II-IIIb), compared with matched patients who underwent the same procedure in an open fashion during the same period. Sixty case-matched patients were evaluated (30 laparoscopic vs. 30 open). Operative time was significantly longer (p<0.05) for LDG. Benefits for LDG (p<0.05) were observed among surgical short-term outcome (postoperative hospital stay, ambulation, first bowel movement, first flatus, first stool, first eating and use of analgesic drugs) and postoperative non-surgical site complications (cardiopulmonary, urinary, etc.). The 42 months' overall survival was similar (p = 0.646). Laparoscopic gastrectomy is a safe technique in a non-academic hospital setting for locally advanced gastric cancer; it seems to be adequate in terms of margin status and adequate lymph node retrieval and is associated with additional benefits as a decreased length of hospital stay, a decreased narcotic use and fewer complications. © 2011 Springer-Verlag.

引用

页码：17 / 23

页数：6

共 39 条

[1]

Nagai Y., Tanimura H., Takifuji K., Kashiwagi H., Yamoto H., Nakatani Y., Laparoscope-assisted Billroth i gastrectomy, Surg Laparosc Endosc, 5, 4, pp. 281-287, (1995)

[2]

Kitano S., Shimoda K., Miyahara M., Shiraishi N., Bandoh T., Yoshida T., Et al., Laparoscopic approaches in the management of patients with early gastric carcinomas, Surg Laparosc Endosc, 5, 5, pp. 359-362, (1995)

[3]

Uyama I., Sugioka A., Matsui H., Fujita J., Komori Y., Hasumi A., Laparoscopic D2 lymph node dissection for advanced gastric cancer located in the middle or lower third portion of the stomach, Gastric Cancer, 3, 1, pp. 50-55, (2000)

[4]

Fleshman J.W., Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial, Ann Surg, 246, (2007)

[5]

Rodriguez Santiago J.M., Clemares M., Roig-Garcia J., Asensio J.I., Feliu X., Toscano E., Et al., Gastric cancer and laparoscopy: Analysis of data from the National register of laparoscopic gastric surgery, Circ Esp, 85, 5, pp. 280-286, (2009)

[6]

Bonenkamp J.J., Hermans J., Sasako M., Van De Velde C.J.H., Extended lymph-node dissection for gastric cancer, New England Journal of Medicine, 340, 12, pp. 908-914, (1999)

[7]

Cuschieri A., Weeden S., Fielding J., Bancewicz J., Craven J., Joypaul V., Sydes M., Fayers P., Patient survival after D<sub>1</sub> and D<sub>2</sub> resections for gastric cancer: Long-term results of the MRC randomized surgical trial, British Journal of Cancer, 79, 9-10, pp. 1522-1530, (1999)

[8]

Hartgritik H.H., Van De Velde C.J.H., Putter H., Bonenkamp J.J., Kranenbarg E.K., Songun I., Welvaart K., Van Krieken J.H.J.M., Meijer S., Plukker J.T.M., Van Elk P.J., Obertop H., Gouma D.J., Van Lanschot J.J.B., Taat C.W., De Craaf P.W., Von Meyenfeldt M.F., Tilanus H., Sasako M., Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial, Journal of Clinical Oncology, 22, 11, pp. 2069-2077, (2004)

[9]

Wu C.W., Hsiung C.A., Lo S.S., Hsieh M.C., Chen J.H., Li A.F., Et al., Nodal dissection for patients with gastric cancer: A randomised controlled trial, Lancet Oncol, 7, 4, pp. 309-315, (2006)

[10]

Edwards P., Blackshaw G.R.J.C., Lewis W.G., Barry J.D., Allison M.C., Jones D.R.B., Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma, British Journal of Cancer, 90, 10, pp. 1888-1892, (2004)

← 1 2 3 4 →